CD274 and neoplasm: Standalone MRI in immunotherapy settings suffers pseudoprogression, where T2-weighted imaging LLDTs result in edema (signals rise in 45–55%) but lacks the ability to differentiate between this and actual tumor progression unless the imaging is accompanied by immune-related biomarkers, such as PD-L1 expression, leading to delayed treatment in not one-fifth of cases [190].